Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gloria J. Young"'
Visual Function at the Atrophic Border in Choroideremia Assessed with Adaptive Optics Microperimetry
Autor:
Gloria J. Young, Albert M. Maguire, William S. Tuten, David H. Brainard, Tomas S. Aleman, Jessica I. W. Morgan, Jean Bennett, Grace Vergilio
Publikováno v:
Ophthalmol Retina
Purpose Recent advances in retinal imaging allow visualization of structural abnormalities in retinal disease at the cellular level. This study used adaptive optics (AO) microperimetry to assess visual sensitivity with high spatial precision and to e
Autor:
Mani Mahmoudian, Elena S. Nikonova, Aimee E. Willett, Puya Aravand, Manzar Ashtari, Jean Bennett, Gui-Shuang Ying, Wei Pan, Kathleen A. Marshall, Albert M. Maguire, Gloria J. Young
Publikováno v:
Ophthalmology. 124:873-883
Purpose Gene therapy (GT) has offered immense hope to individuals who are visually impaired because of RPE65 mutations. Although GT has shown great success in clinical trials enrolling these individuals, evidence for stability and durability of this
Autor:
Gonzalo J. Domingo, Wendy S. Stevens, Kara M. Palamountain, Marco Schito, Shaffiq Essajee, Elliot P. Cowan, Laura T. Mazzola, Jeff Baker, Mutsumi Metzler, Gloria J. Young
Publikováno v:
The Journal of Infectious Diseases. 205:S181-S190
In recent years, there has been significant investment from both the private and public sectors in the development of diagnostic technologies to meet the need for human immunodeficiency virus (HIV) and tuberculosis testing in low-resource settings. F
Autor:
Achilles Katamba, Ilesh V. Jani, David W. Dowdy, Marco Schito, Kara M. Palamountain, Amy S. Piatek, Sean Cavanaugh, William Coggin, Shaffiq Essajee, Eugen Ermantraut, Heather Alexander, Gonzalo J. Domingo, Trevor Peter, Gloria J. Young, Dennis Ellenberger
Publikováno v:
Journal of Infectious Diseases. 205:S169-S180
Stakeholders agree that supporting high-quality diagnostics is essential if we are to continue to make strides in the fight against human immunodeficiency virus (HIV) and tuberculosis. Despite the need to strengthen existing laboratory infrastructure
Autor:
Philip A. Cook, David Leopold, James C. Gee, Gloria J. Young, Laura Cyckowski, Hui Zhang, Jean Bennett, Manzar Ashtari, Elena S. Nikonova, Kathleen A. Marshall, Chris I. Baker, Albert M. Maguire
Publikováno v:
Molecular Therapy. 24:S105
Leber's Congenital Amaurosis (LCA) is an incurable eye disease. Due to slow retinal degeneration, LCA patients with RPE65 gene mutations (LCA2) are good candidates for gene therapy (GT). LCA2 patients in a Phase 1 clinical trial showed improvement in